Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 49 | 57 | 21 | 30 | 33 |
| Cost of Goods | N/A | N/A | N/A | 69 | 77 |
| Gross Profit | 49 | 203 | 21 | -39 | -44 |
| Operating Expenses | 4,344 | 5,612 | 6,542 | 4,725 | 3,185 |
| Operating Income | -4,295 | -5,555 | -6,521 | -4,695 | -3,152 |
| Other Income | 634 | 1,166 | 136 | -156 | -668 |
| Pre-tax Income | -3,661 | -4,389 | -6,385 | -4,851 | -3,820 |
| Net Income Continuous | -3,661 | -4,389 | -6,385 | -4,851 | -3,820 |
| Net Income | $-3,661 | $-4,389 | $-6,385 | $-4,851 | $-3,820 |
| EPS Basic Total Ops | -0.08 | -0.09 | -0.13 | -0.10 | -0.08 |
| EPS Basic Continuous Ops | -0.08 | -0.09 | -0.13 | -0.10 | -0.08 |
| EPS Diluted Total Ops | -0.08 | -0.09 | -0.13 | -0.10 | -0.08 |
| EPS Diluted Continuous Ops | -0.08 | -0.09 | -0.13 | -0.10 | -0.08 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.09 | -0.13 | -0.10 | N/A |
| EBITDA(a) | $-4,248 | $-5,385 | $-6,493 | $-4,666 | $-3,123 |